×
Skip to content
ShareCafe

  • Home
  • Shares
  • Financial Products
  • Video
  • Contributors
  • Community
  • About us
  • Facebook
  • Twitter
  • YouTube
  • RSS
Main Menu

Don Hamson

Don is the founding Managing Director of Plato Investment Management. He is well known as a leader in the practical application of after-tax investing. Prior to forming Plato, Don was Head of Active Equities, Asia Pacific at State Street Global Advisors.

Economics / Funds / Markets

Retirees Join The Beekeepers As The Dividend Honeypot Swells

May 18, 2021May 19, 2021 - by Don Hamson

Plato’s Dr Don Hamson has a look at the biggest takeaways from last week’s budget and the continued resurgence of dividend payouts among the major stocks.

Read More
Funds / Markets

Upgraded ASX Yield Forecast Good News for Retirees

March 15, 2021March 15, 2021 - by Don Hamson

Plato Investment Management forecasts the ASX200 index will return a 4.8% gross yield in 2021, up from the 4.1% their modelling was forecasting at the end of last year. 

Read More
Markets / Strategy

It’s Not All Gloom And Doom For Dividends

September 1, 2020 - by Don Hamson

Plato Investment Management’s Managing Director, Dr. Don Hamson says investors must look beyond the headlines when considering their income strategy over the next 12 months.

Read More
Interest Rates / Strategy

Investing For Retirement Just Got Harder: Where To Invest With Record Low Interest Rates

October 3, 2019October 3, 2019 - by Don Hamson

Investors, particularly Australia’s 3.8 million retirees and self-managed super-funds, should review their income-generating investment strategy in light of the Reserve Bank of Australia’s (RBA) third rate cut decision.

Read More
LICs / Shares

Leading LIC Increases Special Dividend Taking Annual Dividend Yield To 11.9%

May 3, 2019May 3, 2019 - by Don Hamson

The Board of Plato Income Maximiser Limited (ASX: PL8) has announced an increase in the special dividend to 3 cents per share, taking the annual dividend yield to 11.9% (including franking).

Read More
Markets / Shares

A Strong Year For Dividends Globally – Plato

February 7, 2019February 7, 2019 - by Don Hamson

Despite global share markets falling heavily in the last quarter, 2018 was a strong year for dividends across developed markets, with $A1.8 trillion paid out to shareholders, a $200+ billion, or 12.6%, increase from the year before according to research by Plato Investment Management.

Read More
Shares / Strategy

Which Individuals May Be Impacted By The ALP Franking Credit Proposal?

November 7, 2018May 7, 2019 - by Don Hamson

Dr Don Hamson discusses which individuals, investing in their own names, may be impacted by the ALP proposal to no longer refund franking credits.

Read More
Shares

New Survey Supports Calls For Amendments To Labor’s Franking Policy

October 31, 2018October 31, 2018 - by Don Hamson

A survey of investors has found the Australian Labor Party’s (ALP) proposed changes to Australia’s dividend imputation system would result in nearly half (44%) of respondents expecting to be more reliant on the aged pension.

Read More
Strategy

Retirees Cautioned To Be Aware Of ‘Fake Income’

May 22, 2018February 7, 2019 - by Don Hamson

Investors, especially retirees, seeking income from their investments have today been cautioned to be aware of ‘fake income’.

Read More
Strategy

Robbing Granny In The Name Of Paul?

March 22, 2018February 7, 2019 - by Don Hamson

When I was first asked to comment about the ALP’s proposed scrapping of franking credit refunds my response was I was “flabbergasted”.

Read More
Strategy

4 Things Retirees Should Remember About Shares

March 27, 2017February 7, 2019 - by Don Hamson

Aussie retirees have a love affair with shares, but not all share portfolios are created equal when it comes to providing sustainable income.

Read More
  • Crunch Time for Rio with Turquoise Hill
  • Chinese Economy Takes Another Turn for the Worse
  • Having Conquered Oz, JB HiFi Takes on New Zealand
  • Bourse Discourse: ARG, BEN, BPT
  • Fidelity Future Leaders Fund ‘Super’ Series: Innovators
  • What to Expect from AREITs this Reporting Season
  • Lunch Report: 15 August, 2022
  • Stocks of the Hour: 15 August, 2022

Subscribe to ShareCafe

The daily resource for hands-on investors. Market insights and investment ideas delivered free to your inbox.

Copyright 2020 Informed Investor Pty Ltd ABN 42 162 871 589. All rights reserved.
No portion of this website maybe reproduced, copied or in any way released without written permission.
Share Cafe is a Corporate Authorised Representative (001283561) of Sequoia Asset Management Pty Limited who holds an Australian Financial Services Licence (Number: 341506)

Terms of Service | Privacy Policy | Contact | Advertise

DOWNLOAD RESEARCH REPORT

Paxalisib Misses AGILE Hurdle, but Very Significant Value Remains

Investors Over-React, Smart Ones Will Profit

Kazia Therapeutics (KZA) announced yesterday morning that paxalisib did not meet the threshold to move into stage 2 of the GBM AGILE clinical trial (NCT03970447). The study was an adaptive trial designed to assess the potential of new therapeutics to treat the highly aggressive brain cancer glioblastoma (GBM) in a cost-effective manner. Demonstrating efficacy in GBM is an extremely high hurdle as shown by the fact that there is only one approved drug for the disease, temozolomide, and it is only effective in 1/3 of patients.

Given the high nature of the hurdle, in our original initiating coverage report on KZA, we only gave paxalisib a small chance of returning a positive result from the overall study. That is the nature of drug development with one group estimating only 6% to 7% of new chemical entities that commence clinical trials reach launch (Dowden & Munro (2019) Nat Rev Drug Discov). The small percentage that do make it to launch, however, more than make up for the cash spent on those that don’t.

    SMSFBrokerFinancial Adviser

    Please prove you are human by selecting the Plane.

    DOWNLOAD RESEARCH REPORT

    The Cash keeps coming

    Terracom will report their FY2022 results in September 2022. In the last two months there have been a number of company announcements that have given us improved visibility on our earnings forecasts and valuation metrics so we have taken this opportunity to update our numbers.

    With the combination of geopolitical factors in the northern hemisphere as well as disruption from other supply regions, we believe the visibility on export coal prices over the next 12 months has also improved since our March note.

      SMSFBrokerFinancial Adviser

      Please prove you are human by selecting the Cup.

      DOWNLOAD RESEARCH REPORT

      Acquisitions underpin strong near term growth opportunities not reflected in share price

      Stealth Global Holdings (SGI) provides direct exposure to the growing industrial consumables market, driven by favourable conditions across key industries, expanding industrialisation and improving workplace safety regulations. Around 95% of revenue is attributable to non-discretionary items.

      Based on our current forecasts, we derive a DCF equity value for SGI of $0.33 per share, with potential upside if full synergies can be extracted. We note SGI is currently trading on very undemanding forward multiples.

        SMSFBrokerFinancial Adviser

        Please prove you are human by selecting the Heart.

        DOWNLOAD RESEARCH REPORT

        4Q reveals more focus on profit and cash flow

        • LBY’s 4Q FY22 quarterly activities update showed continued solid growth in top line metrics, albeit slowing, with GMV of NZ$203m (+26% on pcp) and income of NZ$12.1m (+23% on pcp).
        • Net Transaction Margin (NTM) disappointed at -0.5%, due to further increase in credit losses from 4.0% to 4.9% of GMV. However, new fraud and credit risk management tools have seen losses recover materially with NTM back to 1.2% in March and LBY is confident of further recovery in coming months.

          SMSFBrokerFinancial Adviser

          Please prove you are human by selecting the Cup.

          DOWNLOAD RESEARCH REPORT

          Signs MOU with Ford Company – Kachi is now sold out!

          Lake Resources (LKE. ASX) – LKE has signed two non-binding MOU’s in the space of 10 days. Ford Company (Ford) has signed an MOU for ~25,000t/year and last week Hanwa, a Japanese commodity trader signed a MOU for up to 25,000t/year. Subject to execution, this is an amazing feat as Ford and Hanwa are prepared to enter into longer-term strategic partnerships with LKE. Commercial negotiations are still ongoing but are expected, especially if Ford & Hanwa inject new equity into LKE, to further de-risk the project financing & thus ensure LKE and Kachi are fully funded.

            SMSFBrokerFinancial Adviser

            Please prove you are human by selecting the Star.

            DOWNLOAD RESEARCH REPORT

            Strategic Vanadium-battery growth with Titanium & Iron earnings resiliency

            TNG Ltd is an ASX-listed technology owner and developer of the world-class Mount Peake near-surface vanadiferous titanomagnetite deposit. To unlock value, TNG will concentrate ore from its central Northern Territory mine for processing through its patented TIVAN® process produce three premium quality revenue streams: hi-purity vanadium pentoxide (V2O5) for steel alloys and Vanadium Redox Flow batteries, a quality titanium pigment for paints and a premium steel input with >64%Fe iron ore fines.

              SMSFBrokerFinancial Adviser

              Please prove you are human by selecting the Star.

              Promising exploration and development update while SOP prices continue to rise

              Two recent gravity surveys have considerably exceeded expectations and revealed potential for extensions to the existing MRE at Lake Throssell, plus a material growth opportunity at Lake Yeo. This reinforces the potential for a multi-decade, Tier-1 SOP production hub based around Lake Throssell.

              TMG is currently completing work towards the PFS due early 2023, including drilling to start in Q3 2022, evaporation trials and permitting activities. Results from these programs will support the PFS and any future resource upgrade.

              Benchmark SOP prices have risen to ~US$940/t due to recent geopolitical developments. The Oct 2021 Scoping Study assumed a SOP price of US$550/t and contained a sensitivity analysis showing every 10% increase in price drives a +$144m increase in the project NPV of $364m. The c.70% increase above the Scoping Study thus implies a project NPV of ~$1.4bn.

              DOWNLOAD RESEARCH REPORT

                SMSFBrokerFinancial Adviser

                Please prove you are human by selecting the Star.

                DOWNLOAD RESEARCH REPORT

                Biopharmas Hit, but Buying Opportunities Created

                The news being reported about the performance of biotechnology has been dour, to say the least, for some time now. Those dour articles have been deserved with the iShares Biotechnology Exchange-Traded Fund down 25% and the SPDR® S&P® Biotech ETF is down 45% from their highs. However, those articles are backward-looking, and successful investors need to be looking forward.

                Recently, however, an article in Nature Reviews Drug Discovery caught our eye which we believe should point the way forward for the vast majority of Australian biotechnology investors. This article indicates that, at least, two companies, Antisense Therapeutics (ANP) and Kazia Therapeutics (KZA), are right in the sweet spot in terms of the future of drug development.

                  SMSFBrokerFinancial Adviser

                  Please prove you are human by selecting the Heart.

                  DOWNLOAD RESEARCH REPORT

                  Hitting goals – Making four material announcements

                  We initiated on Magnis Energy Technologies (MNS.ASX) in December 2021 and since then, MNS has made four material announcements. Firstly; a conditional offtake contract for 600,000t of graphite concentrate from the Tanzanian Nachu Project (net 100%) was signed with Traxys, a global
                  commodities merchant with annual revenue of ~US$6Bn; secondly; semi autonomous production has started at battery gigafactory iM3NY, thirdly;
                  exciting Extra Fast Charge battery tests were reported and most recently, the game changing launch of the Lithium Slim Energy Reserve battery platform, which supports C4V’s growing EFC capability.

                    SMSFBrokerFinancial Adviser

                    Please prove you are human by selecting the Heart.

                    DOWNLOAD RESEARCH REPORT

                    Increasing our Target

                    Despite the lower realised oil and gas price, which fell by 5.4% and 19.7% respectively in August, Calima managed to show improvement in its key business metrics.

                    We expect higher production in November due to the contribution by the new Thorsby wells which will be drilled in August/September which will see Calima meet its 2021 production guidance of 4,500 boe/d.

                      SMSFBrokerFinancial Adviser

                      Please prove you are human by selecting the Heart.

                      DOWNLOAD RESEARCH REPORT

                      Emerging Financial Wealth Advisory Group

                      WT Financial Group Limited (WTL) is a growing diversified financial services company, founded in 2010 and listed on the Australian Stock Exchange (ASX) in 2015. Its advice and product offerings are delivered primarily through a group of independent financial advisers operating as authorised representatives of WTL under its Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group) dealer group operations. It has around 275 advisers across more than 200 financial advice practices Australia-wide. It also operates a direct-to-consumer operation under its Spring Financial Group brand.

                        SMSFBrokerFinancial Adviser

                        Please prove you are human by selecting the Cup.

                        DOWNLOAD RESEARCH REPORT
                        Immutep Taking the Fight to Cancer

                        In May 2021, Corporate Connect analyst Marc Sinatra published a comprehensive research report on ASX-listed biotech Immutep Ltd (ASX: IMM). So impressed was he with IMM that Corporate Connect felt it imperative that a follow-up report be released placing a valuation on the company, because the market was not seeing the vast potential of eftilagimod alpha (efti).

                        This follow-up report has been released today. Using comparables, after adding cash back to their EV estimate and dividing by the total number of issued shares, Corporate Connect now places the fair value of an Immutep share at $A2.20.

                          SMSFBrokerFinancial Adviser

                          Please prove you are human by selecting the Tree.

                          DOWNLOAD RESEARCH REPORT

                          Phillips 66 to acquire 16% in NVX – 12-month target price rises 7% through project de-risking

                          Phillips 66 (PSX) has entered into an agreement with NVX to acquire 77.9m new shares for US$150m (A$203m). PSX is the worlds largest producer of speciality petroleum coke a precursor for battery grade synthetic graphite anode materials found with an Enterprise Value of US$47.5Bn and assets of US$57Bn.

                            SMSFBrokerFinancial Adviser

                            Please prove you are human by selecting the Truck.

                            DOWNLOAD RESEARCH REPORT

                            Market leading lifelong learning platform technology company in Australia and SE Asia

                            PayGroup (PYG) delivers multi-country BPO services and cloud SaaS HCM solutions, assisting companies to manage employees in multiple, complex jurisdictions. The company has many growth opportunities, including new clients, new jurisdictions, new products, partner expansion, and new revenue sources. PYG’s scalable business model allows operating leverage and with savings from in-housing third party technology, support margin expansion.

                              SMSFBrokerFinancial Adviser

                              Please prove you are human by selecting the Truck.

                              DOWNLOAD RESEARCH REPORT

                              Market leading lifelong learning platform technology company in Australia and SE Asia

                              OpenLearning (OLL) is a higher education technology company that operates a scalable online learning platform through a software-as-a-service (SaaS) business model and provides a global marketplace of high quality courses for learners of all levels. Its primary customers are education providers based in Australia and South-East Asia (primarily Malaysia). OLL started operations in Australia in 2012 and expanded to Malaysia in 2015, Singapore in 2018, and recently also Indonesia.

                                SMSFBrokerFinancial Adviser

                                Please prove you are human by selecting the Heart.